Effects of FODMAPs on Small Bowel Water Content: an MRI Study
Launched by UNIVERSITY OF NOTTINGHAM · Oct 24, 2011
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
Title: Effects of FODMAPs (Fermentable Oligo-, Di-, and Mono-saccharides, And Polyols) on small bowel water content: an MRI study
1. Background. FODMAPs consist of fructose, lactose, fructo- and galacto-oligosaccharides such as fructans and galactans, and polyols such as sorbitol and mannitol. These carbohydrates are poorly absorbed in the small intestine and have been shown to trigger symptoms of irritable bowel syndrome (IBS). Previous studies have shown that fructose malabsorption results in an increased osmotic load in the small bowel, which can have a laxative effect. Physical proof o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Apparently healthy: no medical conditions which might effect study measurements.
- • No reported participation in another nutritional or biomedical trial 3 months before the pre-study examination or during the study.
- • Age ≥ 18 and ≤ 60 year at pre-study investigation.
- • Body mass index (BMI) ≥ 18.0 and ≤ 30.0 kg/m2
- • No reported participation in night shift work two days prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM.
- • Strenuous exercise ≤ 10 hours per week.
- • Gender: male or female
- • Consumption of ≤ 21 alcoholic drinks in a typical week
- • Currently not smoking
- • Suitable for MRI scanning (e.g., absence of metal implants, infusion pumps and pacemakers) as assessed by the attached MRI safety questionnaire.
- Exclusion Criteria:
- • - use of medication which interferes with study measurements or bowel motility (as judged by the study physician).
- • Antibiotics in the 3 weeks before pre-study examination
- • Probiotics or during the study
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Trial Officials
Robin C Spiller, MD FRCP
Principal Investigator
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials